SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056203
Filing Date
2021-11-10
Accepted
2021-11-10 16:16:14
Documents
71
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sdgr-10q_20210930.htm   iXBRL 10-Q 4345171
2 EX-31.1 sdgr-ex311_7.htm EX-31.1 21602
3 EX-31.2 sdgr-ex312_6.htm EX-31.2 21625
4 EX-32.1 sdgr-ex321_10.htm EX-32.1 5790
5 EX-32.2 sdgr-ex322_11.htm EX-32.2 5943
  Complete submission text file 0001564590-21-056203.txt   11320469

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20210930.xsd EX-101.SCH 60886
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sdgr-20210930_cal.xml EX-101.CAL 53399
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdgr-20210930_def.xml EX-101.DEF 238496
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20210930_lab.xml EX-101.LAB 453888
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20210930_pre.xml EX-101.PRE 357110
11 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-10q_20210930_htm.xml XML 1824478
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39206 | Film No.: 211396836
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences